Grants for For profit organizations other than small businesses - Federal
Explore 1,390 grant opportunities
Application Deadline
Mar 31, 2025
Date Added
Jan 7, 2025
This funding opportunity provides financial support to organizations that will create a mentorship network for women in the strategic trade field, promoting their professional development and collaboration.
Application Deadline
May 20, 2024
Date Added
Mar 20, 2024
The U.S. Department of States Embassy Astana announces an open competition opportunity to implement a project that strengthens Kazakhstans media environment through the provision of legal support to journalists who may need assistance; legal-related training for journalists and media content creators, law students or practitioners; ethics and management training for journalists and media outlets; and educational initiatives targeting law enforcement to raise awareness about the rights of journalists. The project aims to promote professional journalism standards and ensure proper legal protections where needed, while supporting Kazakhstans efforts towards democracy and rule of law. Providing legal assistance is crucial in addressing the prevalent issue of journalists facing harassment and intimidation. This support helps safeguard press freedom, ensuring their ability to report freely and holding accountable those who seek to suppress their work. Priority will be given to projects that focus on and provide evidence of tangible, measurable results. Projects consisting solely of conferences or roundtable discussions, theoretical research or surveys, or the writing or publishing of books, are unlikely to be funded. The United States of America and the Republic of Kazakhstan collaborate extensively on bilateral and regional matters, including support for Kazakhstan's commitment to safeguarding media freedoms and elevating journalistic professionalism. Legal protection is foundational to a safe environment for journalism practice, ensuring the safety of journalists and their ability to fulfill their duties. Equally crucial is the need for journalists and content creators to be well-versed in their rights and responsibilities as outlined by the law. This knowledge extends to law students, practitioners, and law enforcement, fostering a holistic understanding of media law. In addition to safeguarding media freedoms, enhancing ethics and management practices helps ensure a robust and well-functioning media landscape. The objective is to not only level the media playing field for independent outlets, but also to empower them with the skills needed to navigate economic challenges, such as financial generation management and resilience during economic downturns. In line with these goals, the U.S. Embassy seeks to facilitate collaboration between various stakeholders by partnering with a qualified non-profit organization in implementing a program. This initiative aims to provide legal support as well as ethics and management training to journalists, content creators, law students, practitioners, and law enforcement in Kazakhstan, bridging the gap between legal expertise and the media landscape. Project Audience(s): The project should target journalists, media professionals, media content makers, law students and practitioners, and law enforcement agents throughout the country. The project should be able to provide services in Kazakh and Russian. Project Goal: Strengthen press freedom and independence in Kazakhstan by providing access to legal support services and training programs to media and legal professionals. Project Objectives: The program should support objective journalism and ethical journalism standards through the provision of timely, exhaustive, and comprehensive legal consultations to journalists, content creators, law students and practitioners, and media consultants. The program should be able to provide pro-bono legal support in cases when a journalist or a media outlet, requesting such support, were fulfilling their professional duties in accordance with international journalism standards and ethics, as well as the laws and regulations of the Republic of Kazakhstan. The program must include media rights and responsibilities trainings for journalists and content creators, law students and practitioners, and for law enforcement agencies. Proposals should outline strategies and activities aimed at empowering media entities to build strong and sustainable management practices. This may include initiatives focused on financial generation management, strategic planning, and resilience-building measures to navigate economic challenges and enhance the overall managerial competence of independent media organizations. The DREAM Initiative encompasses three key lines of effort to fortify independent media in Kazakhstan: Legal Support, Ethics and Management Training, and Media Transparency. These objectives align with the overarching goal of fostering objective journalism and ethical standards. Project proposals may address one or more of these objectives, or other objectives within the above policy priorities. Objective 1: Improve knowledge and awareness of legal rights and media laws among a minimum of 100 participants through a series of six training sessions. (Ensure at least half of the training sessions are conducted in Kazakh). Topics may include media laws, ethical journalism standards and management practices, journalist legal protections and emerging legal challenges. Objective 2: Advocate for enforcement of legislation that uphold international journalism standards and legal protections by providing media professionals access to timely legal support and consultation services. Objective 3: Improve the ability of independent media organizations, including media executives, editors, and journalists to implement effective management practices through capacity building training focused on organizational management, strategic planning, developing diversified revenue streams, and ethical journalism practices.
Application Deadline
Jul 19, 2024
Date Added
May 2, 2024
The FY24 PCRP Idea Development Award is intended to support new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP mission. The key components of this award mechanism are: Innovation: Research deemed innovative may represent a new paradigm, challenge current paradigms, look at existing problems from new perspectives, leverage unique study populations, or exhibit other highly creative qualities. Research that is an incremental advance upon published data is not considered innovative. Projects involving multidisciplinary and/or data science approaches are especially encouraged. Impact: Applications are required to address and provide a solution to one or more of the FY24 PCRP Overarching Challenges. The potential impact of the research, both short-term and long-term, in addressing the FY24 PCRP Overarching Challenge(s) should be clearly described. High-impact research will, if successful, significantly advance prostate cancer research and/or patient care. Preliminary Data: Due to this awards emphasis on innovation, the presentation of preliminary data relevant to prostate cancer and the proposed project is encouraged, but not required. Any unpublished, preliminary data provided should originate from the laboratory of the Principal Investigator (PI) or a member(s) of the research team. Regardless of whether preliminary data are included, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature.New Investigator category: The FY24 PCRP Idea Development Award mechanism encourages research ideas from investigators in the early stages of their careers. The New Investigator category of this award mechanism is designed to allow applicant organizations to name PIs who are early in their faculty appointments or in the process of developing independent research careers. Applications submitted to the New Investigator category will be assessed using different review criteria for personnel (refer to Section II.E.1.a., Peer Review) and are required to include a collaborator (or collaborators) who has (have) experience in prostate cancer research, as demonstrated by a record of funding and publications. The application must describe the potential of the collaboration(s) to be successful and how the collaboration(s) will augment the PIs expertise to better address the research question. In addition, applicants are strongly encouraged to provide a letter of collaboration from the collaborator(s) describing the collaborator(s) involvement in the proposed work. All applicants for the New Investigator category must meet specific eligibility criteria described in Section II.C, Eligibility Information.Multidisciplinary projects are encouraged, and multi-institutional projects are allowed. Each proposed study must include a clearly stated plan for interactions among all team members and organizations involved. The plan must include communication, coordination of research progress and results, and data transfer. Additionally, multi-institutional applications must provide an intellectual property plan to resolve potential intellectual and material property issues and to remove institutional barriers that might interfere with achieving high levels of cooperation to ensure the successful completion of this award.Investigators are strongly encouraged to incorporate the following components into their study design, where appropriate, in order to maximize the potential impact of the proposed research project: authentication of proposed cell lines; statistical rigor of preclinical animal experiments; and incorporation of experiments to assess clinical relevance and translatability of findings. Studies utilizing data that are derived from large patient studies that include long-term health records, biospecimen repositories, and pre-existing research and apply state-of-the-art genomic and/or proteomic analysis, bioinformatics, and/or mathematical models to such data are also encouraged. Investigators are highly encouraged to provide a letter of support indicating access to and the availability of any resources required to support the study.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, the CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 PCRP priorities.Innovative research involving nuclear medicine and related techniques to support early diagnosis, more-effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs (VA), and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research.All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of clinical and preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 https://www.nature.com/nature/ journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies.Clinical trials are not allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated direct costs budgeted for the entire period of performance for an FY24 PCRP Idea Development Award should not exceed $1.2M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $53.76M to fund approximately 28 Idea Development Award applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.
Application Deadline
Oct 31, 2024
Date Added
Aug 13, 2024
This funding opportunity provides support for research institutions to conduct early-phase clinical trials focused on cancer prevention interventions across various organ sites.
Application Deadline
Sep 30, 2025
Date Added
Jun 4, 2025
This funding opportunity supports innovative scientific research and technology development relevant to maritime applications, inviting proposals from academia, industry, and research institutions, including Historically Black Colleges and Universities and Minority Institutions.
Application Deadline
Oct 1, 2025
Date Added
May 27, 2025
This grant provides funding for collaborative research teams of independent investigators to advance innovative solutions in melanoma prevention, treatment, and survivorship, with a focus on improving patient outcomes.
Application Deadline
Dec 16, 2024
Date Added
Nov 8, 2024
This funding opportunity provides financial support to organizations working to improve health behaviors in Tanzania through social and behavior change initiatives, targeting issues like malaria, maternal and child health, and HIV/AIDS.
Application Deadline
Not specified
Date Added
Aug 22, 2024
This grant provides funding to improve primary health care services in Togo by enhancing their quality and community responsiveness, particularly for vulnerable groups like women, children, and people living with HIV/AIDS.
Application Deadline
Oct 3, 2024
Date Added
Apr 24, 2024
The DoD Tick-Borne Disease, Idea Development Award is a grant aimed at funding innovative research that could significantly advance the understanding and treatment of Lyme disease and other tick-borne diseases, ultimately improving the lives of military personnel, veterans, their families, and the general public.
Application Deadline
Nov 19, 2024
Date Added
Feb 15, 2024
This funding opportunity is designed to support innovative citizen science projects that engage the public in space and Earth science research, encouraging collaboration between scientists and community members.
Application Deadline
Sep 15, 2024
Date Added
Aug 16, 2024
The U.S. Department of State Bureau of Economic and Business Affairs (EB) announces an open competition for organizations to submit a statement of interest (SOI) to carry out a program under the International Technology Security and Innovation (ITSI) Fund, created by the CHIPS Act of 2022. Please carefully follow all instructions below. The submission of the SOI is the first step in a two-step process. Applicants must first submit a concise no more than three (3) page statement of interest designed to clearly communicate the program idea and objectives. This is not a full proposal. The purpose of the SOI process is to allow applicants to submit program ideas for evaluation prior to requiring the development of a full proposal application. Upon a merit review of eligible SOIs, selected applicants will be invited to expand on their program idea(s) by submitting a full proposal application. Full proposals will go through a second merit review before final funding decisions are made. EB administers a portion of the ITSI Fund, the ITSI Promote line of effort, to help expand international semiconductor assembly, testing, and packaging (ATP or downstream) capacity in key partner countries that will in turn diversify the global semiconductor supply chain. EBs objectives under the ITSI Fund are to: 1) Expand and diversify the required workforce for semiconductor ATP facilities to ensure growth; and 2) Improve regulatory environments that will encourage private sector efforts that generate additional capabilities in ATP facilities. This solicitation is specific to Vietnam and includes two (2) categories under which applicants may submit SOIs: 1) Workforce Development, and 2) Policy and Regulatory Reform. See "Related Documents" tab for attached RSOI background, illustrative activities, and submission instructions.If you have any questions about the SOI application process, please contact [email protected] by August 2, 2024. Emails must reference the funding opportunity number DFOP0016759 in the subject line. FAQ will be posted by August 10, 2024. SOIs may be submitted via email to [email protected].
Application Deadline
Not specified
Date Added
May 14, 2022
This grant provides funding for researchers studying ancient sediments and fossils to better understand the Earth's history, environmental changes, and the evolution of life before the Holocene epoch.
Application Deadline
Jun 20, 2024
Date Added
May 21, 2024
The Federal and State Technology (FAST) Partnership Program provides funding to organizations to execute state/regional programs that increase the number of SBIR/STTR proposals leading to an increase in the number of SBIR/STTR awards from women, socially/economically disadvantaged individuals, and small businesses in underrepresented areas - typically rural states.
Application Deadline
Jul 12, 2024
Date Added
Jun 11, 2024
The U.S. Department of State, Bureau of Democracy, Human Rights, and Labor (DRL) announces an open competition for organizations interested in submitting applications for a project that supports the meaningful political and civic participation of youth in the Solomon Islands.
Application Deadline
Aug 22, 2024
Date Added
Jul 24, 2024
The project seeks to strengthen the capacity of civil society organizations in Peru to identify, analyze, expose, and fight against corruption and impunity. By developing civil societys capacity to hold government institutions accountable, INL seeks to create solid foundations for a comprehensive effort to identify and expose corrupt acts and impunity.
Application Deadline
Dec 2, 2024
Date Added
Sep 27, 2024
This funding opportunity provides financial support for U.S.-based organizations, including private companies, universities, and nonprofits, to advance the development of innovative fuel cell and electrolysis technologies for efficient hydrogen production.
Application Deadline
Jul 31, 2024
Date Added
Jun 27, 2024
U.S. Embassy Mexico City of the U.S. Department of State announces an open competition for organizations to submit applications to carry out a program to promote workforce development in the printed circuit board (PCB) industry through curriculum development for PCB focused courses at secondary and tertiary educational levels, certificate programs, vocational instruction, dual education, technical English language skills building, and full or partial support for internships in Taiwanese PCB manufacturing firms either in Taiwan or Mexico.
Application Deadline
May 5, 2024
Date Added
Mar 19, 2024
The U.S. Embassy is pleased to announce a call for proposals from individuals and organizations for its English-Language Program for Disadvantaged Communities. The program is focused on English-language training for youth aged 12-17 from underserved communities, especially those located outside of the capital city. In addition to in-person programs, instruction may be offered partly virtually. The program objectives are: To offer free-of-charge English-language instruction to Azerbaijani students from underserved communities. To create highly effective English-language instruction using current, student-centered methodologies to improve the students ability to comprehend and communicate in real-world contexts. To instill knowledge of and appreciation for American culture and values, to promote community service, and to enhance critical-thinking skills among program participants. Participants and Audiences: The intended audiences for potential projects are individuals from disadvantaged communities (rural areas, low-income, IDPs etc.). Secondary school students and young people living in rural and vulnerable communities are the targeted beneficiaries and special consideration will be given to programs working in regions outside of Baku. Proposed programs should include contingency plans to accommodate potential prohibitions on in-person gatherings.
Application Deadline
Jul 3, 2024
Date Added
Feb 25, 2024
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Institute of Neurological Disorders and Stroke (NINDS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and National Heart, Lung and Blood Institute (NHLBI), intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational, and clinical research and provide important resources that can be used by the national muscular dystrophy research communities. The Centers also provide outstanding environments for the training of new researchers capable of addressing high priority objectives in muscular dystrophy research. Center investigators are expected to participate in important community outreach efforts to increase awareness of their research activities among people with lived experience and the related advocacy communities and to incorporate community perspectives into the conduct of patient-centered research. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New and Renewal applications will be eligible. This NOFO will utilize the P50 activity code. Details of the planned NOFO are provided below.
Application Deadline
Not specified
Date Added
Sep 27, 2024
This grant provides funding to researchers and institutions to create expanded access programs for ALS patients who are ineligible for traditional clinical trials, allowing them to receive investigational treatments.
